Moderna will employ the same mRNA vaccine technology that was pioneered to develop COVID-19 vaccines.
In the ongoing waves of bird flu outbreaks, with the virus spreading to more than 141 herds in 12 states, the risk of another full-blown pandemic like COVID-19 is becoming a distinct possibility. In preparation for just such a disaster, the U.S. government will pay pharmaceutical company Moderna $176 million to develop a vaccine that protects against the H5N1 virus. Moderna will employ the same...
